Jane Street’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-15,010
| Closed | -$397K | – | 5943 |
|
|
2022
Q2 | $397K | Buy |
+15,010
| New | +$397K | ﹤0.01% | 3799 |
|
|
2020
Q1 | – | Sell |
-22,283
| Closed | -$519K | – | 3606 |
|
|
2019
Q4 | $519K | Sell |
22,283
-6,773
| -23% | -$158K | ﹤0.01% | 2207 |
|
|
2019
Q3 | $592K | Sell |
29,056
-1,927
| -6% | -$39.3K | ﹤0.01% | 2037 |
|
|
2019
Q2 | $655K | Buy |
30,983
+16,915
| +120% | +$358K | ﹤0.01% | 2033 |
|
|
2019
Q1 | $301K | Sell |
14,068
-23,277
| -62% | -$498K | ﹤0.01% | 2691 |
|
|
2018
Q4 | $717K | Buy |
+37,345
| New | +$717K | ﹤0.01% | 1796 |
|
|
2018
Q3 | – | Sell |
-45,294
| Closed | -$983K | – | 3617 |
|
|
2018
Q2 | $983K | Buy |
+45,294
| New | +$983K | ﹤0.01% | 1668 |
|
|
2018
Q1 | – | Sell |
-23,910
| Closed | -$512K | – | 3247 |
|
|
2017
Q4 | $512K | Buy |
+23,910
| New | +$512K | ﹤0.01% | 2008 |
|